CGEN — COMPUGEN LTD

—
Nasdaq · Health Care · Biotechnology · CIK 1119774 ·
Last close
$2.02
Market Cap
$191.34M
52W High
$3.24
52W Low
$1.43
ADV30
231,913
Next earnings
2026-11-09

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 3,821,000 1,421,000 -6,846,000 -5,800,000 129,534,000 7,061,000 46,171,000
Jun 2026 — — — — — — —
Mar 2026 2,176,000 352,000 -9,017,000 -7,669,000 145,861,000 12,435,000 50,508,000
Dec 2025 67,332,000 63,796,000 56,043,000 56,845,000 156,570,000 90,597,000 53,839,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-453,415,000
Inventory
—
Receivables
$2,338,000
ST Investments
$122,511,000
EBIT TTM
$30,704,000
Pretax Income TTM
$34,883,000
Interest Exp TTM
—
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$74,001,000
EBITDA
$30,676,000
Free Cash Flow
$22,217,000
Enterprise Value
$111,691,640
Total Cash
$125,300,000
Total Debt
$3,023,000
Shares Out
94,724,146
Trailing EPS
$0.38
Book Value
$0.94
ROE
50.6%
ROA
15.5%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 72,764,000 31,326,000 35,343,000 156,570,000 53,839,000 102,731,000 31,634,000
Dec 2024 27,864,000 -14,891,000 -14,231,000 114,995,000 60,081,000 54,914,000 49,604,000
Dec 2023 33,459,000 -12,992,000 -18,754,000 121,334,000 55,775,000 65,559,000 -35,886,000
Dec 2022 7,500,000 -35,374,000 -33,694,000 94,176,000 16,496,000 77,680,000 -34,113,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.37

Peers — same industry

TickerNameMarket CapLastDaily %
ARTV Artiva Biotherapeutics, Inc. $190.81M $3.86 —
IKT Inhibikase Therapeutics, Inc. $193.57M $1.38 —
DTIL PRECISION BIOSCIENCES INC $196.95M $7.05 —
PALI PALISADE BIO, INC. $181.07M $1.01 —
LCTX Lineage Cell Therapeutics, Inc. $206.36M $0.82 —

News headlines (Yahoo Finance, 1h cache)

Compugen Ltd (CGEN) Q3 2026 Earnings Call Highlights: Revenue Doubles as Gilead and AstraZeneca ...
2026-11-12 23:03 · Yahoo
Compugen to Present UnigenX™ Platform at the 18th Annual PEGS Europe Summit
2026-11-10 12:00 · Yahoo
Compugen Ltd. Q3 2026 Earnings Call Summary
2026-11-09 17:44 · Yahoo
What Compugen (CGEN) Said on Its Q3 Earnings Call
2026-11-09 15:14 · Yahoo
Compugen: Q3 Earnings Snapshot
2026-11-09 12:06 · Yahoo
Compugen Reports Third Quarter 2026 Results
2026-11-09 12:00 · Yahoo
Compugen to Participate in November Investor Conferences
2026-11-03 12:00 · Yahoo
Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets
2026-10-05 21:02 · Yahoo
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-08 11:00 · Yahoo
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ...
2026-08-06 01:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.